SPONSOR
Huazhong University of Science and Technology
Total Trials
3
Recruiting
3
Phases
Phase 2
Huazhong University of Science and Technology is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Delirium, Colorectal Cancer, Diffuse Large B Cell Lymphoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huazhong University of Science and Technology
How many clinical trials has Huazhong University of Science and Technology sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Huazhong University of Science and Technology, of which 3 are actively recruiting participants. These trials cover conditions including Delirium, Colorectal Cancer, Diffuse Large B Cell Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huazhong University of Science and Technology research focus on?
Huazhong University of Science and Technology clinical trials span Delirium, Colorectal Cancer, Diffuse Large B Cell Lymphoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huazhong University of Science and Technology clinical trial?
To participate in a Huazhong University of Science and Technology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huazhong University of Science and Technology trials with current recruitment status updated daily.
Clinical Trials by Huazhong University of Science and Technology
NCT04832568
Recruiting
Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery
Delirium
NCT06168786 Phase 2
Recruiting
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Colorectal Cancer
NCT06005870 Phase 2
Recruiting
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
Diffuse Large B Cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology